BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Amanda Abdel-Al, Eman El-Ahwany, Mona Zoheiry, Marwa Hassan, Amged Ouf, Hoda Abu-Taleb, Ali Abdel Rahim, Mohamed Darwish El-Talkawy, Suher Zada. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patientsVirus Research 2018; 253: 135 doi: 10.1016/j.virusres.2018.06.007
2
Bing Han, Yujia Zheng, Le Wang, Haixu Wang, Jiaxin Du, Fanglei Ye, Tongwen Sun, Lianfeng Zhang. A novel microRNA signature predicts vascular invasion in hepatocellular carcinomaJournal of Cellular Physiology 2019;  doi: 10.1002/jcp.28690
3
Hailong Wang, Xiu Xin, Mingzhen Wang, Lingling Han, Jiadai Li, Yao Hao, Congyi Zheng, Chao Shen. Myxovirus resistance protein A inhibits hepatitis C virus replication through JAK-STAT pathway activationArchives of Virology 2018; 163(6): 1429 doi: 10.1007/s00705-018-3748-3
4
Monjur Ahmed. Era of direct acting anti-viral agents for the treatment of hepatitis CWorld Journal of Hepatology 2018; 10(10): 670-684 doi: 10.4254/wjh.v10.i10.670
5
Yu-Lung Chiu, Herng-Ching Lin, Nai-Wen Kao, Senyong Kao, Hsin-Chien Lee. Increased risk of concurrent hepatitis C among Male patients with schizophreniaPsychiatry Research 2017; 258: 217 doi: 10.1016/j.psychres.2017.08.036
6
Momoko Iwamoto, Aurelie Calzia, Amelie Dublineau, François Rouet, Janin Nouhin, Sokchea Yann, Sophorn Pin, Chhorvy Sun, Kimchamroeun Sann, Chhit Dimanche, Celine Lastrucci, Rebecca M. Coulborn, David Maman, Jean-Philippe Dousset, Anne Loarec. Field evaluation of GeneXpert® (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in CambodiaJournal of Viral Hepatitis 2019; 26(1): 38 doi: 10.1111/jvh.13002
7
Kiyotaka Yamazaki, Dendy Macaulay, Yan Song, Yuri Sanchez Gonzalez. Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims DataInfectious Diseases and Therapy 2019; 8(2): 285 doi: 10.1007/s40121-019-0234-5
8
L H Zain, T Sungkar. Management of hepatitis C infection in the era of direct-acting antiviral therapyIOP Conference Series: Earth and Environmental Science 2018; 125: 012087 doi: 10.1088/1755-1315/125/1/012087
9
Yucel Aydin, Christopher M. Stephens, Srinivas Chava, Zahra Heidari, Rajesh Panigrahi, Donkita D. Williams, Kylar Wiltz, Antoinette Bell, Wallace Wilson, Krzysztof Reiss, Srikanta Dash. Chaperone-Mediated Autophagy Promotes Beclin1 Degradation in Persistently Infected Hepatitis C Virus Cell CultureThe American Journal of Pathology 2018; 188(10): 2339 doi: 10.1016/j.ajpath.2018.06.022
10
Amina A. Negash, Rebecca M. Olson, Stephen Griffin, Michael Gale, Christopher M. Walker. Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activationPLOS Pathogens 2019; 15(2): e1007593 doi: 10.1371/journal.ppat.1007593
11
Qunying Han, Xiude Fan, Xiaoyun Wang, Ye Wang, Huan Deng, Xiaoge Zhang, Kun Zhang, Na Li, Zhengwen Liu. High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world settingVirology Journal 2019; 16(1) doi: 10.1186/s12985-019-1184-y
12
Michael Bowsher, Sheldon Hiebert, Rongti Li, Alan X. Wang, Jacques Friborg, Fei Yu, Dennis Hernandez, Ying-Kai Wang, Herbert Klei, Ramkumar Rajamani, Kathy Mosure, Jay O. Knipe, Nicholas A. Meanwell, Fiona McPhee, Paul M. Scola. The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 proteaseBioorganic & Medicinal Chemistry Letters 2018; 28(1): 43 doi: 10.1016/j.bmcl.2017.11.005
13
María Q. Marín, Patricia Pérez, Karl Ljungberg, Carlos Óscar S. Sorzano, Carmen E. Gómez, Peter Liljeström, Mariano Esteban, Juan García-Arriaza, J.-H. James Ou. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCVJournal of Virology 2019; 93(7) doi: 10.1128/JVI.00055-19
14
Laura Pimpin, Helena Cortez-Pinto, Francesco Negro, Emily Corbould, Jeffrey V. Lazarus, Laura Webber, Nick Sheron. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policiesJournal of Hepatology 2018; 69(3): 718 doi: 10.1016/j.jhep.2018.05.011
15
Matthias Van Haele, Janne Snoeck, Tania Roskams. Human Liver Regeneration: An Etiology Dependent ProcessInternational Journal of Molecular Sciences 2019; 20(9): 2332 doi: 10.3390/ijms20092332
16
Marta Miarons, Azhara Sánchez-Ulayar, Glòria Sempere, Sergio Marín, Josep Maria Castellví. New direct-acting antivirals for hepatitis C treatment and neuropsychiatric symptoms in psychiatric risk groupsEuropean Journal of Hospital Pharmacy 2019; 26(3): 135 doi: 10.1136/ejhpharm-2017-001352
17
Malgorzata Pawlowska, Malgorzata Sobolewska-Pilarczyk, Krzysztof Domagalski. Hepatitis C virus infection in children in the era of direct-acting antiviralWorld Journal of Gastroenterology 2018; 24(24): 2555-2566 doi: 10.3748/wjg.v24.i24.2555
18
Fahimeh Ranjbar Kermani, Sedigheh Amini-Kafiabad, Kamran Mousavi Hosseini, Mahtab Maghsudlu, Zohreh Sharifi, Mohammad Ali Mansournia. Distribution of Hepatitis C Virus Genotypes and Related Risk Factors Among Iranian Blood Donors: A Penalized Logistic RegressionJundishapur Journal of Microbiology 2018; 11(12) doi: 10.5812/jjm.69136
19
Luis Antonio Uribe-Noguez, Alicia Ocaña-Mondragón, José Antonio Mata-Marín, María Elena Gómez-Torres, Rosa María Ribas-Aparicio, María de la Luz Martínez-Rodríguez. Presence of rare hepatitis C virus subtypes, 2j, 2k, and 2r in Mexico City as identified by sequencingJournal of Medical Virology 2018; 90(7): 1277 doi: 10.1002/jmv.25070
20
Dong Wook Jekarl, Hyunyu Choi, Seungok Lee, Jung Hyun Kwon, Sung Won Lee, Hein Yu, Myungshin Kim, Yonggoo Kim, Pil Soo Sung, Seung Kew Yoon. Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B PatientsAnnals of Laboratory Medicine 2018; 38(4): 348 doi: 10.3343/alm.2018.38.4.348
21
Zobair M. Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V. Nguyen, Ching Lung Lai, Henry Lik-Yuen Chan, Lai Wei. Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infectionJournal of Viral Hepatitis 2018; 25(12): 1429 doi: 10.1111/jvh.12965
22
Marianna Zając, Izabela Muszalska, Agnieszka Sobczak, Adrianna Dadej, Szymon Tomczak, Anna Jelińska. Hepatitis C – New drugs and treatment prospectsEuropean Journal of Medicinal Chemistry 2019; 165: 225 doi: 10.1016/j.ejmech.2019.01.025
23
Jia Li, Stuart C. Gordon, Loralee B. Rupp, Talan Zhang, Sheri Trudeau, Scott D. Holmberg, Anne C. Moorman, Philip R. Spradling, Eyasu H. Teshale, Joseph A. Boscarino, Mark A. Schmidt, Yihe G. Daida, Mei Lu. Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetesAlimentary Pharmacology & Therapeutics 2019; 49(5): 599 doi: 10.1111/apt.15102
24
Mohsen Gadallah, Sahar Kandil, Amira Mohsen. Association between hepatitis C infection and cerebro-cardiovascular disease: analysis of a national population-based survey in EgyptTropical Medicine & International Health 2018; 23(7): 738 doi: 10.1111/tmi.13068
25
Mohamed A. Daw. Hepatitis C in Developing Countries2018; : 57 doi: 10.1016/B978-0-12-803233-6.00006-0
26
Yu Xiang, Xiao-fei Lai, Pu Chen, Yang Yang. The correlation of HCV RNA and HCV core antigen in different genotypes of HCVJournal of Clinical Laboratory Analysis 2019; 33(1): e22632 doi: 10.1002/jcla.22632
27
Lia Goncalves Possuelo, Daiane Perin, Patricia Faber Breunig, Daniel Felipe Schroeder, Manuela Filter Allgayer, Camilo Darsie, Marcelo Carneiro, Vanda Hermes, Jane Dagmar Pollo Renner. Hepatitis C: evaluation of outcomes and georeferencing of cases in Santa Cruz do Sul, Brazil, between 2002 and 2015. A cross-sectional studySao Paulo Medical Journal 2017; 136(2): 109 doi: 10.1590/1516-3180.2017.0169180917
28
Víctor Granados-García, Yvonne N. Flores, Lizbeth I. Díaz-Trejo, Lucia Méndez-Sánchez, Stephanie Liu, Guillermo Salinas-Escudero, Filiberto Toledano-Toledano, Jorge Salmerón, Vincenzo De Luca. Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysisPLOS ONE 2019; 14(2): e0212558 doi: 10.1371/journal.pone.0212558
29
Benli Jia, Yong Wang, Gang Yu, Yunsheng Cheng, Chuang Yang, Feng Cao, Yan He, Pengwei Cao, Xiangling Meng, Dongsheng Yu. Naringenin ameliorates insulin resistance by modulating endoplasmic reticulum stress in hepatitis C virus-infected liverBiomedicine & Pharmacotherapy 2019; 115: 108848 doi: 10.1016/j.biopha.2019.108848
30
Jin Zhang, Xing Gao, Yuan Yuan, Chao Sun, Yuanlin Zhao, Liming Xiao, Ying Yang, Yu Gu, Risheng Yang, Peizhen Hu, Lijun Zhang, Chao Wang, Jing Ye. Perilipin 5 alleviates HCV NS5A-induced lipotoxic injuries in liverLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1022-7
31
Arnolfo Petruzziello. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular CarcinomaThe Open Virology Journal 2018; 12(1): 26 doi: 10.2174/1874357901812010026
32
Marisa Silbernagl, Rudolf Slamanig, Gabriele Fischer, Laura Brandt. Hepatitis C infection and psychiatric burden in two imprisoned cohorts: Young offenders and opioid-maintained prisonersHealth Policy 2018; 122(12): 1392 doi: 10.1016/j.healthpol.2018.10.005
33
Andrew H Talal, Phyllis Andrews, Anthony Mcleod, Yang Chen, Clewert Sylvester, Marianthi Markatou, Lawrence S Brown. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on MethadoneClinical Infectious Diseases 2019; 69(2): 323 doi: 10.1093/cid/ciy899
34
Arnolfo Petruzziello, Giovanna Loquercio, Rocco Sabatino, Daniel Vasile Balaban, Najeeb Ullah Khan, Mauro Piccirillo, Luis Rodrigo, Lucia di Capua, Annunziata Guzzo, Francesco Labonia, Gerardo Botti. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic reviewJournal of Clinical Laboratory Analysis 2019; 33(5): e22876 doi: 10.1002/jcla.22876
35
Arnolfo Petruzziello, Rocco Sabatino, Giovanna Loquercio, Annunziata Guzzo, Lucia Di Capua, Francesco Labonia, Anna Cozzolino, Rosa Azzaro, Gerardo Botti, Yury E. Khudyakov. Nine-year distribution pattern of hepatitis C virus (HCV) genotypes in Southern ItalyPLOS ONE 2019; 14(2): e0212033 doi: 10.1371/journal.pone.0212033
36
Nelson Veiga Gonçalves, Claudia do Socorro Carvalho Miranda, Juan Andrade Guedes, Larissa de Cássia Tork da Silva, Elizabeth Maciel Barros, Cileide Gomes da Mota Tavares, Vera Regina da Cunha Menezes Palácios, Simone Beverly Nascimento da Costa, Helena Cunha Oliveira, Marília Brasil Xavier. Hepatites B e C nas áreas de três Centros Regionais de Saúde do Estado do Pará, Brasil: uma análise espacial, epidemiológica e socioeconômicaCadernos Saúde Coletiva 2019; 27(1): 1 doi: 10.1590/1414-462x201900010394
37
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Carmela Cacciapuoti. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in EuropeInfectious Agents and Cancer 2016; 11(1) doi: 10.1186/s13027-016-0099-0
38
Ahmed A. Ezat, Wael M. Elshemey. A comparative study of the efficiency of HCV NS3/4A protease drugs against different HCV genotypes using in silico approachesLife Sciences 2019; 217: 176 doi: 10.1016/j.lfs.2018.12.004
39
Babita Agrawal, Shakti Singh, Nancy Gupta, Wen Li, Satish Vedi, Rakesh Kumar. Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another DimensionInternational Journal of Molecular Sciences 2017; 18(8): 1626 doi: 10.3390/ijms18081626
40
Elena Chernykh, Olga Leplina, Ekaterina Oleynik, Marina Tikhonova, Tamara Tyrinova, Natalia Starostina, Alexandr Ostanin. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial)Immunologic Research 2018; 66(1): 31 doi: 10.1007/s12026-017-8967-2
41
Luis Antonio Uribe-Noguez, Alicia Ocaña-Mondragón, José Antonio Mata-Marín, Allison Cázares-Cortázar, Rosa María Ribas-Aparicio, María Elena Gómez-Torres, Jesus Gaytán-Martínez, María de la Luz Martínez-Rodríguez. Case report: Identification of recombinant HCV genotype 1b–2b by viral sequencing in two patients with treatment failure, who responded to re-treatment with sofosbuvir and daclatasvirJournal of Infection and Chemotherapy 2018; 24(11): 928 doi: 10.1016/j.jiac.2018.04.001
42
Dariush Naghipour-Khalkhaliani, Daryoush Behzadpour, Seyed Dawood Mousavi Nasab. Distribution of Hepatitis C Virus Genotypes in Rasht, Capital City of Guilan Province, Northern Part of IranHepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.62030
43
Rui Huang, Huiying Rao, Jia Shang, Hong Chen, Jun Li, Qing Xie, Zhiliang Gao, Lei Wang, Jia Wei, Jianning Jiang, Jian Sun, Jiaji Jiang, Lai Wei. A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5DHealth and Quality of Life Outcomes 2018; 16(1) doi: 10.1186/s12955-018-0941-8
44
Resat Ozaras, Hakan Leblebicioglu. Viral Hepatitis: Chronic Hepatitis C2019; : 1 doi: 10.1007/978-3-030-03757-4_1
45
Pamela S. Belperio, Troy A. Shahoumian, Timothy P. Loomis, Larry A. Mole, Lisa I. Backus. Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3Journal of Hepatology 2019; 70(1): 15 doi: 10.1016/j.jhep.2018.09.018
46
Amina Adadi, Safae Adadi, Mohammed Berrada. Gastroenterology Meets Machine Learning: Status Quo and Quo VadisAdvances in Bioinformatics 2019; 2019: 1 doi: 10.1155/2019/1870975
47
José A. Gálvez, Rafael Clavería-Gimeno, Juan J. Galano-Frutos, Javier Sancho, Adrian Velázquez-Campoy, Olga Abian, María D. Díaz-de-Villegas. Stereoselective synthesis and biological evaluation as inhibitors of hepatitis C virus RNA polymerase of GSK3082 analogues with structural diversity at the 5-positionEuropean Journal of Medicinal Chemistry 2019; 171: 401 doi: 10.1016/j.ejmech.2019.03.019
48
Elizabeth Buganza-Torio, Karen Elizabeth Doucette. Management of Viral Hepatitis in Solid Organ Transplant RecipientsInfectious Disease Clinics of North America 2018; 32(3): 635 doi: 10.1016/j.idc.2018.04.010
49
Mohammad Sultan Khuroo. Viral Hepatitis: Acute Hepatitis2019; : 77 doi: 10.1007/978-3-030-03535-8_6
50
Sevin Kirdar, Neriman Aydin, Yasin Tiryaki, Bulent Ertugrul, Adil Coskun, Mehmet Bilgen. Dynamics of HCV epidemiology in Aydin province of Turkey and the associated factorsAPMIS 2018; 126(2): 109 doi: 10.1111/apm.12790
51
V. S. Kichatova, A. A. Karlsen, O. V. Isaeva, S. A. Solonin, E. Yu. Malinnikova, K. K. Kyuregyan, M. I. Mikhailov. Drug resistant variants of hepatitis C virus genotype 1b in Russia: analysis of aminoacid substitutions in NS5a and core proteinsJournal Infectology 2018; 10(4): 30 doi: 10.22625/2072-6732-2018-10-4-30-36
52
Emily Nguyen, Sam Trinh, Huy Trinh, Huy Nguyen, Khanh Nguyen, Aivien Do, Brian Levitt, Son Do, My Nguyen, Treta Purohit, Eugenie Shieh, Mindie H. Nguyen. Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvirAlimentary Pharmacology & Therapeutics 2019; 49(1): 99 doi: 10.1111/apt.15043
53
Andrey V. Barkhash, Galina V. Kochneva, Elena V. Chub, Aida G. Romaschenko. Single nucleotide polymorphism rs1800872 in the promoter region of the IL10 gene is associated with predisposition to chronic hepatitis C in Russian populationMicrobes and Infection 2018; 20(3): 212 doi: 10.1016/j.micinf.2017.11.012
54
Natasha K. Martin, Lara K. Marquez. Disease Modelling and Public Health, Part BHandbook of Statistics 2017; 37: 93 doi: 10.1016/bs.host.2017.08.007
55
Sara Lo Menzo, Enrico Biagi, Mariachiara Di Nuzzo, Anastasio Grilli, Carlo Contini. SVR 24 Achievement Two Weeks After a Tripled Dose of Daclatasvir in an HCV Genotype 3 PatientAnnals of Hepatology 2018; 17(4): 661 doi: 10.5604/01.3001.0012.0950
56
Elisabete Andrade, Daniele Rocha, Marcela Fontana-Maurell, Elaine Costa, Marisa Ribeiro, Daniela Tupy de Godoy, Antonio G.P. Ferreira, Amilcar Tanuri, Patrícia Alvarez, Rodrigo Brindeiro. One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in BrazilThe Brazilian Journal of Infectious Diseases 2018; 22(5): 418 doi: 10.1016/j.bjid.2018.08.003
57
Christine Chang, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu. Hepatitis C core antigen highly correlated to HCV RNAThe Kaohsiung Journal of Medical Sciences 2018; 34(12): 684 doi: 10.1016/j.kjms.2018.08.002
58
Petra Surlin, Dorin Nicolae Gheorghe, Liliana Foia, Amelia Surdu, Vasilica Toma, Sorina Mihaela Solomon, Dan Nicolae Florescu, Ion Rogoveanu. Hepatitis C - From Infection to Cure2018;  doi: 10.5772/intechopen.76135
59
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and PathogenesisJournal of Clinical Medicine 2017; 6(12): 111 doi: 10.3390/jcm6120111
60
Ahmed Mohammed Gaballah, Marwa Mohammed Esawy. Comparison of 2 different antibody assay methods, Elecsys Anti-HCVII (Roche) and Vidas Anti-HCV (Biomerieux), for the detection of antibody to hepatitis C virus in EgyptDiagnostic Microbiology and Infectious Disease 2018; 92(2): 107 doi: 10.1016/j.diagmicrobio.2018.05.013
61
Lucy Somerville, Karen Doucette. Hepatitis C: Current Controversies and Future Potential in Solid Organ TransplantationCurrent Infectious Disease Reports 2018; 20(7) doi: 10.1007/s11908-018-0625-x
62
M. Conti, T. Matulli Cavedagna, E. Ramazzotti, R. Mancini, L. Calza, M. Rinaldi, L. Badia, V. Guardigni, P. Viale, G. Verucchi. Multiplexed therapeutic drug monitoring (TDM) of antiviral drugs by LC–MS/MSClinical Mass Spectrometry 2018; 7: 6 doi: 10.1016/j.clinms.2017.12.002
63
Ahmed Atef Mesalam, Isabelle Desombere, Ali Farhoudi, Freya Van Houtte, Lieven Verhoye, Jonathan Ball, Jean Dubuisson, Steven K.H. Foung, Arvind H. Patel, Mats A.A. Persson, Geert Leroux-Roels, Philip Meuleman. Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1Virology 2018; 514: 30 doi: 10.1016/j.virol.2017.10.019
64
Abdel-Rahman N. Zekri, Abeer A. Bahnassy, Mona S. Abdellateif. Hepatitis C - From Infection to Cure2018;  doi: 10.5772/intechopen.76763
65
Nicola Coppola, Loredana Alessio, Lorenzo Onorato, Caterina Sagnelli, Margherita Macera, Evangelista Sagnelli, Mariantonietta Pisaturo. Epidemiology and management of hepatitis C virus infections in immigrant populationsInfectious Diseases of Poverty 2019; 8(1) doi: 10.1186/s40249-019-0528-6
66
Jae-Cheol Kwon, Hye Young Chang, Oh Young Kwon, Ji Hoon Park, In Soo Oh, Hyung Joon Kim, Jun Hyung Lee, Ha-Jung Roh, Hyun Woong Lee. Seroepidemiology of Hepatitis Viruses and Hepatitis B Genotypes of Female Marriage Immigrants in KoreaYonsei Medical Journal 2018; 59(9): 1072 doi: 10.3349/ymj.2018.59.9.1072
67
Gary M. Clifford, Tim Waterboer, Bolormaa Dondog, You Lin Qiao, Dimitri Kordzaia, Doudja Hammouda, Namory Keita, Nahid Khodakarami, Syed Ahsan Raza, Ang Tshering Sherpa, Witold Zatonski, Michael Pawlita, Martyn Plummer, Silvia Franceschi. Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and AfricaInfectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0121-1
68
Ajit Sood, A. Suryaprasad, A. Trickey, S. Kanchi, V. Midha, M. A. Foster, E. Bennett, S. Kamili, F. Alvarez-Bognar, S. Shadaker, V. Surlikar, R. Garg, P. Mittal, S. Sharma, M. T. May, P. Vickerman, F. Averhoff, Sibnarayan Datta. The burden of hepatitis C virus infection in Punjab, India: A population-based serosurveyPLOS ONE 2018; 13(7): e0200461 doi: 10.1371/journal.pone.0200461
69
Cesar Henriquez-Camacho, Núria Serre, Francesca Norman, Adrián Sánchez-Montalvá, Diego Torrús, Ane Josune Goikoetxea, Juan María Herrero-Martínez, José Manuel Ruiz-Giardín, Begoña Treviño, Begoña Monge-Maillo, Israel Molina, Azucena Rodríguez, Magdalena García, Rogelio López-Vélez, José A. Pérez-Molina, Paloma Aguilera, María Martínez Serrano, Magdalena García Rodriguez, Marta Díaz Menendez, Yolanda Meije, Joaquim Martínez-Montauti, Xavier Sanz, Isabel Pacheco Tenza, Inmaculada Gonzalez Cuello, Belén Martínez López, Jara LLenas, Mar Masiá, Sergio Padilla, Mónica Romero, Philip Wilkman-Jorgensen, Diego Torrús, José Manuel Ramos Rincón, Eduardo Malmierca, Ana Perez-Ayala, Juan María Herrero, Manuel Lizasoain, Pablo Rojo, Mariano Matarranz, Carlos Zarco, Azucena Rodriguez-Guardado, Jonathan Fernández Suárez, Jose Antonio Boga Ribeiro, Josune Goikoetxea Aguirre, Miren Zuriñe Zubero Sulibarría, José Manuel Ruiz Giardin, Juan Victor Sanmartín López, María Velasco Arribas, Eva Calabuig Muñoz, Ana Mena Ribas, María Peñaranda Vera, Israel Molina, Adrián Sánchez Montalvá, Fernando Salvador, Ángel Dominguez, Francesca Norman, Begoña Treviño-Maruri, Nuria Serre Delcor, Antonio Soriano-Arandes, Diana Pou Ciruelo, Cristina Bocanegra. Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi networkTravel Medicine and Infectious Disease 2019; 29: 51 doi: 10.1016/j.tmaid.2019.02.001
70
Jia-Horng Kao, Chun-Yen Lin, Wan-Long Chuang, Yao-Yun Cheng, Jui-Yu Hu, Wen-Kai Liang, Peter Friebe, Stuart Palmer, Chin-Shiou Huang. Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotypingDiagnostic Microbiology and Infectious Disease 2019; 94(4): 344 doi: 10.1016/j.diagmicrobio.2019.02.020
71
Bin Wei, Fanpu Ji, Yee Hui Yeo, Eiichi Ogawa, Christopher D Stave, Shuangsuo Dang, Zongfang Li, Norihiro Furusyo, Ramsey C Cheung, Mindie H Nguyen. Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in AsiaBMJ Open Gastroenterology 2018; 5(1): e000209 doi: 10.1136/bmjgast-2018-000209
72
Jian Zhang, Wen Sun, Jun Lin, Ye Tian, Linlin Ma, Lei Zhang, Yichen Zhu, Wei Qiu. Long-term follow-up of HCV infected kidney transplant recipients receiving direct-acting antiviral agents: a single-center experience in ChinaBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4217-7
73
Bing-Ru Wu, Auda A. Eltahla, Elizabeth Keoshkerian, Melanie R. Walker, Alex Underwood, Nicholas A. Brasher, David Agapiou, Andrew R. Lloyd, Rowena A. Bull. A method for detecting hepatitis C envelope specific memory B cells from multiple genotypes using cocktail E2 tetramersJournal of Immunological Methods 2019; 472: 65 doi: 10.1016/j.jim.2019.06.016
74
Petra E de Ruiter, Yashna Gadjradj, Robert J de Knegt, Herold J Metselaar, Jan NM Ijzermans, Luc JW van der Laan. Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acidWorld Journal of Transplantation 2018; 8(5): 156-166 doi: 10.5500/wjt.v8.i5.156
75
Maléki Assih, Abdoul Karim Ouattara, Birama Diarra, Albert Theophane Yonli, Tegwindé Rebeca Compaore, Dorcas Obiri-Yeboah, Florencia Wendkuuni Djigma, Simplice Karou, Jacques Simpore. Genetic diversity of hepatitis viruses in West-African countries from 1996 to 2018World Journal of Hepatology 2018; 10(11): 807-821 doi: 10.4254/wjh.v10.i11.807
76
You-Wen Tan, Yan Tao, Long-Gen Liu, Yun Ye, Xin-Bei Zhou, Li Chen, Cong He. Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period surveyWorld Journal of Gastroenterology 2018; 24(11): 1250-1258 doi: 10.3748/wjg.v24.i11.1250
77
Zobair M. Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young-Suk Lim, Yock Young Dan, Ming-Lung Yu, Maria Stepanova. Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East AsiaAlimentary Pharmacology & Therapeutics 2019; 49(6): 644 doi: 10.1111/apt.15131
78
Rania A. Zayed, Dalia Omran, Abeer A. Zayed, Lobna O. Elmessery. Determinants of Infection Outcome in HCV-Genotype 4Viral Immunology 2017; 30(8): 560 doi: 10.1089/vim.2017.0071
79
V. S. Kichatova, K. K. Kyuregyan, N. V. Soboleva, A. A. Karlsen, O. V. Isaeva, M. G. Isaguliants, M. I. Mikhailov. Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic ContextJournal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/7685371
80
Muhammad Sarfaraz Iqbal, Usman Ali Ashfaq, Sadia Aslam, Saba Khaliq, Muhammad Usman Ghani, Farzana Batool. Analysis of polymorphism rs1990760 of IFIH1 gene and treatment outcomes in HCV infectionFuture Virology 2018; 13(3): 181 doi: 10.2217/fvl-2017-0116
81
Issam I Raad, Anne-Marie Chaftari, Harrys A Torres, Ehab Mouris Ayoub, Liliane Iskander Narouz, Jalen Bartek, Ray Hachem. Challenge of hepatitis C in Egypt and hepatitis B in MauritaniaWorld Journal of Hepatology 2018; 10(9): 549-557 doi: 10.4254/wjh.v10.i9.549
82
Ashly Maughan, Onyema Ogbuagu. Pegylated interferon alpha 2a for the treatment of hepatitis C virus infectionExpert Opinion on Drug Metabolism & Toxicology 2018; 14(2): 219 doi: 10.1080/17425255.2018.1421173
83
Jose Ramiro Cruz, Rene Berrios Cruz, Jorge Duque Rodríguez, Silvina Kuperman. Blood Safety2019; : 225 doi: 10.1007/978-3-319-94436-4_12
84
Muhammad H. Bashir, Javid Fazili, Mohammad F. Madhoun, Rajesh Kanagala, Sixia Chen, Salman Nusrat. Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosisEuropean Journal of Gastroenterology & Hepatology 2017; : 1 doi: 10.1097/MEG.0000000000001032
85
Asrul Akmal Shafie, Muhammad Radzi Abu Hassan, Norazila Abdul Ghani, Beng Hoong Chew, Nor Syahireen Mohammed. Cost analysis of chronic hepatitis C virus management in a Malaysia tertiary hospitalJournal of Pharmaceutical Health Services Research 2018; 9(2): 141 doi: 10.1111/jphs.12210
86
Sonia Vázquez-Morón, Beatriz Ardizone Jiménez, María A. Jiménez-Sousa, José M. Bellón, Pablo Ryan, Salvador Resino. Evaluation of the diagnostic accuracy of laboratory-based screening for hepatitis C in dried blood spot samples: A systematic review and meta-analysisScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41139-8
87
Takuya Sho, Goki Suda, Megumi Kimura, Tomoe Shimazaki, Osamu Maehara, Taku Shigesawa, Kazuharu Suzuki, Akihisa Nakamura, Masatsugu Ohara, Machiko Umemura, Takaaki Izumi, Naoki Kawagishi, Masaru Baba, Masato Nakai, Mitsuteru Natsuizaka, Kenichi Morikawa, Koji Ogawa, Naoya Sakamoto. Glecaprevir and Pibrentasvir for Japanese Patients with Human Immunodeficiency Virus and Genotype 3 Hepatitis C Virus Coinfection: A Report of Three CasesInternal Medicine 2019; 58(6): 797 doi: 10.2169/internalmedicine.1856-18
88
Anjali Prashar. Shed Tears for Diagnostics2019; : 51 doi: 10.1007/978-981-13-7169-1_5
89
Baomin Liu, Kuo Gai, Hui Qin, Xushi Liu, Yuan Cao, Qin Lu, Dandan Lu, Deyang Chen, Hengqiao Shen, Wei Song, Yang Zhang, Xiaojin Wang, Hongjiang Xu, Yinsheng Zhang. Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activityEuropean Journal of Medicinal Chemistry 2018; 148: 95 doi: 10.1016/j.ejmech.2018.02.025
90
Nancy Reau, Paul Y. Kwo, Susan Rhee, Robert S. Brown, Kosh Agarwal, Peter Angus, Edward Gane, Jia‐Horng Kao, Parvez S. Mantry, David Mutimer, K. Rajender Reddy, Tram T. Tran, Yiran B. Hu, Abhishek Gulati, Preethi Krishnan, Emily O. Dumas, Ariel Porcalla, Nancy S. Shulman, Wei Liu, Suvajit Samanta, Roger Trinh, Xavier Forns. Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus InfectionHepatology 2018; 68(4): 1298 doi: 10.1002/hep.30046
91
Yucel Aydin, Milad Chedid, Srinivas Chava, Donkita Danielle Williams, Shuanghu Liu, Curt H. Hagedorn, Suchitra Sumitran-Holgersson, Krzysztof Reiss, Krzysztof Moroz, Hua Lu, Luis A. Balart, Srikanta Dash. Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV cultureScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10087-6
92
Antoine Chaillon, Sanjay R. Mehta, Martin Hoenigl, Sunil S. Solomon, Peter Vickerman, Matthew Hickman, Britt Skaathun, Natasha K. Martin, Yury E. Khudyakov. Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfectionPLOS ONE 2019; 14(6): e0217964 doi: 10.1371/journal.pone.0217964
93
Sanhua Wei, Yingfeng Lei, Jie Yang, Xiaoyan Wang, Fang Shu, Xin Wei, Fang Lin, Bin Li, Ying Cui, Hai Zhang, Sanhua Wei. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopesVaccine 2018; 36(17): 2273 doi: 10.1016/j.vaccine.2018.03.036
94
Wondmagegn Demsiss, Abdurahaman Seid, Temesgen Fiseha, Isabelle Chemin. Hepatitis B and C: Seroprevalence, knowledge, practice and associated factors among medicine and health science students in Northeast EthiopiaPLOS ONE 2018; 13(5): e0196539 doi: 10.1371/journal.pone.0196539
95
Guilherme Bricks, Jorge Figueiredo Senise, Henrique Pott Junior, Giuliano Grandi, Amanda Passarini, Débora Bellini Caldeira, Dimas Carnaúba Junior, Hamilton Antonio Bonilha de Moraes, Celso Franscisco Hernandes Granato, Adauto Castelo. Seroprevalence of hepatitis E virus in chronic hepatitis C in BrazilThe Brazilian Journal of Infectious Diseases 2018; 22(2): 85 doi: 10.1016/j.bjid.2018.02.001
96
Detection Of Hepatitis C Virus (Hcv) Infection And Its Genotype In Patients At Hepatology Outpatient Clinic, Dr Soetomo General Hospital, Surabaya.IOP Conference Series: Earth and Environmental Science 2019; 217: 012051 doi: 10.1088/1755-1315/217/1/012051
97
David Powell, Abby Alpert, Rosalie L. Pacula. A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis CHealth Affairs 2019; 38(2): 287 doi: 10.1377/hlthaff.2018.05232
98
Amen Bawazir, Fahad AlGusheri, Hoda Jradi, Mohammed AlBalwi, Abdel-Galil Abdel-Gader. Hepatitis C virus genotypes in Saudi Arabia: a future prediction and laboratory profileVirology Journal 2017; 14(1) doi: 10.1186/s12985-017-0873-7
99
Mona Abdel-Hady, Deidre A. Kelly. Reference Module in Biomedical Sciences2019;  doi: 10.1016/B978-0-12-801238-3.65710-0
100
Idris Abdullahi Nasir, Sa’adatu Yakubu, Jelili Olaide Mustapha. Epidemiology and Synergistic Hepatopathology of Malaria and Hepatitis C Virus CoinfectionVirology: Research and Treatment 2017; 8: 1178122X1772441 doi: 10.1177/1178122X17724411
101
Giuseppe Luigi Banna, Francesco Passiglia, Francesca Colonese, Stefania Canova, Jessica Menis, Alfredo Addeo, Antonio Russo, Diego Luigi Cortinovis. Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients’ selectionCritical Reviews in Oncology/Hematology 2018; 129: 27 doi: 10.1016/j.critrevonc.2018.06.016
102
Vahideh Takhviji, Ebrahim Azizi, Ali Kordian, Abbas Khosravi, Mostafa Paridar, Mohammad Ali Jalalifar, Omid Kiani Ghalehsardi, Mohammad Abdollahi, Mofid Hosseinzadeh, Zahra Bakshandeh. Hepatitis C virus prevalence among patients with thalassemia and inherited bleeding disorders in Iran: a systematic review and meta-analysisHematology & Transfusion International Journal 2018; 6(5) doi: 10.15406/htij.2018.06.00175
103
Mohamed F. Montasser, Samy Zaky, Mohamed Salaheldin, Dina Johar, Abdelrahman Ibrahim Abushouk, Fathiya El-Raey, Muneer Al-Husseini, Elsayed G. Mohammed. Fib-4 Predicts Early Hematological Adverse Events Induced by Interferon-Based Triple Therapy in Chronic Hepatitis C Virus PatientsJournal of Interferon & Cytokine Research 2019; 39(2): 85 doi: 10.1089/jir.2018.0131
104
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Nicola Coppola, Mauro Piccirillo, Maddalena Leongito, Rosa Azzaro, Francesco Izzo, Gerardo Botti. Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective studyInfectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0162-5
105
Adam Trickey, Hannah Fraser, Aaron G Lim, Amy Peacock, Samantha Colledge, Josephine G Walker, Janni Leung, Jason Grebely, Sarah Larney, Natasha K Martin, Matthew Hickman, Louisa Degenhardt, Margaret T May, Peter Vickerman. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling studyThe Lancet Gastroenterology & Hepatology 2019; 4(6): 435 doi: 10.1016/S2468-1253(19)30085-8
106
Corrine I. Voils, Heather A. King, Carolyn T. Thorpe, Dan V. Blalock, Ian M. Kronish, Bryce B. Reeve, Colleen Boatright, Ziad F. Gellad. Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C TreatmentDigestive Diseases and Sciences 2019;  doi: 10.1007/s10620-019-05621-7
107
Flavia F. Fernandes, Hugo Perazzo, Luiz E. Andrade, Alessandra Dellavance, Carlos Terra, Gustavo Pereira, João L. Pereira, Frederico Campos, Maria L. Ferraz, Renata M. Perez. Latent Class Analysis of Noninvasive Methods and Liver Biopsy in Chronic Hepatitis C: An Approach without a Gold StandardBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/8252980
108
Xavier A. Andrade, Luis H. Paz, Mo''ath Nassar, Diana M. Oramas, Harry E. Fuentes, Paula Kovarik, Satya Mishra, Anshu Singh. Primary Liver Diffuse Large B-Cell Lymphoma following Complete Response for Hepatitis C Infection after Direct Antiviral TherapyActa Haematologica 2018; 139(2): 77 doi: 10.1159/000484653
109
Guy Rostoker. When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?Seminars in Dialysis 2019; 32(1): 22 doi: 10.1111/sdi.12732
110
Netanel Tzarum, Ian A. Wilson, Mansun Law. The Neutralizing Face of Hepatitis C Virus E2 Envelope GlycoproteinFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01315
111
Alexander Gutwerk, Thomas Wex, Kerstin Stein, Cosima Langner, Ali Canbay, Peter Malfertheiner, Alexander Link. Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide PolymorphismJournal of Clinical Medicine 2018; 7(3): 44 doi: 10.3390/jcm7030044
112
Mohamed A. Daw, Lutfi A. Buktir Ali, Amina M. Daw, Nadia E. M. Sifennasr, Aghnyia A. Dau, Mohamed M. Agnan, Abdallah El-Bouzedi. The geographic variation and spatiotemporal distribution of hepatitis C virus infection in Libya: 2007–2016BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3471-4
113
Guy Rostoker, Nosratola D. Vaziri. Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for cautionHemodialysis International 2017; 21: S68 doi: 10.1111/hdi.12557
114
Satya P. Gupta. Studies on Hepatitis Viruses2018; : 1 doi: 10.1016/B978-0-12-813330-9.00001-6
115
Tawhida Y. Abdel Ghaffar, Suzan El Naghi, Manal Abdel Gawad, Sarah Helmy, Aisha Abdel Ghaffar, Medhat Yousef, Mohamad Moafy. Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4Journal of Viral Hepatitis 2019; 26(2): 263 doi: 10.1111/jvh.13032
116
A.I.K. Mahanama, B. Samaraweera, T.T. Niroshanie, S.S.S.A.K. Seethagala, J.I. Abeynayake. Seroprevalence of hepatitis B and C virus infection among clinically suspected patients at state sector hospitals in Sri Lanka; a laboratory-based retrospective studyInfectious Diseases 2019; : 1 doi: 10.1080/23744235.2019.1640387
117
Aysegul Ozakyol. Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology)Journal of Gastrointestinal Cancer 2017; 48(3): 238 doi: 10.1007/s12029-017-9959-0
118
Ankit Ganeshpurkar, Gopichand Gutti, Sushil Kumar Singh. Viral Polymerases2019; : 1 doi: 10.1016/B978-0-12-815422-9.00001-2
119
Isaac Thom Shawa. Hepatitis B and C [Working Title]2019;  doi: 10.5772/intechopen.82772
120
Andreza Soriano Figueiredo, Elisabeth Lampe, Pedro Pereira Lira Furtado de Albuquerque, Flávia Löwen Levy Chalhoub, Ana Maria Bispo de Filippis, Livia Melo Villar, Oswaldo Gonçalves Cruz, Marcelo Alves Pinto, Jaqueline Mendes de Oliveira. Epidemiological investigation and analysis of the NS5B gene and protein variability of non-primate hepacivirus in several horse cohorts in Rio de Janeiro state, BrazilInfection, Genetics and Evolution 2018; 59: 38 doi: 10.1016/j.meegid.2018.01.017
121
V. Estrada, I. Sagastagoitia. La hepatitis C es un factor de riesgo para enfermedad cardiovascularRevista Clínica Española 2019;  doi: 10.1016/j.rce.2019.01.012
122
Mary Malebranche, Dawn King, Jennifer Leonard. Descriptive epidemiology of hepatitis C in individuals referred for specialized HCV care in Newfoundland and Labrador, 1996–2014Canadian Liver Journal 2018; 1(3): 107 doi: 10.3138/canlivj.2018-0013
123
Sarwat Mahmud, Silva P. Kouyoumjian, Zaina Al Kanaani, Hiam Chemaitelly, Laith J. Abu-Raddad. Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesisAnnals of Epidemiology 2018; 28(7): 452 doi: 10.1016/j.annepidem.2018.03.007
124
Amir Atapour, Pooneh Mokarram, Zohreh MostafaviPour, Seyed Younes Hosseini, Younes Ghasemi, Shiva Mohammadi, Navid Nezafat. Designing a Fusion Protein Vaccine Against HCV: An In Silico ApproachInternational Journal of Peptide Research and Therapeutics 2018;  doi: 10.1007/s10989-018-9735-4
125
Luis Filipe da Costa Marques Borges, Mariano Gustavo Zalis, Guilherme Santoro-Lopes, Rafael Brandão Varella. Hepatitis C virus genotypes in hemodialysis patients in AngolaJournal of Medical Virology 2019; 91(3): 518 doi: 10.1002/jmv.25354
126
Qi Wu, Zhubing Li, Qiang Liu. An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTENVirology 2018; 520: 94 doi: 10.1016/j.virol.2018.05.011
127
Fiona McPhee, Joseph Ueland, Vincent Vellucci, Scott Bowden, William Sievert, Nannan Zhou. Impact of Preexisting Hepatitis C Virus Genotype 6 NS3, NS5A, and NS5B Polymorphisms on the In Vitro Potency of Direct-Acting Antiviral AgentsAntimicrobial Agents and Chemotherapy 2019; 63(4) doi: 10.1128/AAC.02205-18
128
Tapas Patra, Ratna Ray, Ranjit Ray. Strategies to Circumvent Host Innate Immune Response by Hepatitis C VirusCells 2019; 8(3): 274 doi: 10.3390/cells8030274
129
X. M. LI, R. X. QIU, C. H. SONG, Q. H. HUANG, X. D. WANG, Z. T. HU, X. Z. HE, X. Y. YE, X. G. HUANG, F. F. ZHENG, G. X. LIN. Genotype and genetic variation of HCV infections with low-risk factors in Putian coastal regions, ChinaEpidemiology and Infection 2017; 145(16): 3385 doi: 10.1017/S0950268817002357
130
Masako Okada, Hoang Hai, Akihiro Tamori, Sawako Uchida-Kobayashi, Masaru Enomoto, Hiromitsu Kumada, Norifumi Kawada. Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virusClinical Journal of Gastroenterology 2019; 12(3): 213 doi: 10.1007/s12328-018-0922-9
131
Panita Mettikanont, Chalermrat Bunchorntavakul, K. Rajender Reddy. Systematic review: epidemiology and response to direct-acting antiviral therapy in genotype 6 chronic hepatitis C virus infectionAlimentary Pharmacology & Therapeutics 2019; 49(5): 492 doi: 10.1111/apt.15100
132
Batbold Batsaikhan, Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Ping-Hsin Hsieh, Wan-Long Chuang, Jin-Ching Lee, Ming-Lung Yu, Chia-Yen Dai. Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis CJournal of the Chinese Medical Association 2019; 82(4): 277 doi: 10.1097/JCMA.0000000000000064
133
Ahmed Babiker, Jean Jeudy, Seth Kligerman, Miriam Khambaty, Anoop Shah, Shashwatee Bagchi. Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A ReviewJournal of Clinical and Translational Hepatology 2017; 5(4): 1 doi: 10.14218/JCTH.2017.00021
134
The Prevalence of Hepatitis C Virus Infection in Pregnant Women in Duhok City, Kurdistan Region of Iraq: A Brief ReportWomen’s Health Bulletin  doi: 10.5812/whb.91494
135
Marc Puigvehí, Beatriz De Cuenca, Ana Viu, Moisés Diago, Juan Turnes, Francisco Gea, Juan M. Pascasio, Sabela Lens, Joaquín Cabezas, Ester Badia, Antonio Olveira, Rosa M. Morillas, Xavier Torras, Silvia Montoliu, Patricia Cordero, José L. Castro, Javier Salmerón, Esther Molina, Juan J. Sánchez-Ruano, Javier Moreno, María D. Antón, José M. Moreno, Juan De la Vega, José L. Calleja, José A. Carrión. Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohortLiver International 2019; 39(1): 90 doi: 10.1111/liv.13950
136
Winita Hardikar. Viral hepatitisJournal of Paediatrics and Child Health 2019;  doi: 10.1111/jpc.14562
137
Rachel E. Gicquelais, Betsy Foxman, Joseph Coyle, Marisa C. Eisenberg. Hepatitis C transmission in young people who inject drugs: Insights using a dynamic model informed by state public health surveillanceEpidemics 2019; 27: 86 doi: 10.1016/j.epidem.2019.02.003
138
Maher BM. Boraie, Yasser A. Elnaggar, Mohammed Othman Ahmed, Ahmed M. Mahmoud. Effect of direct acting antiviral therapy of Chronic Hepatitis C virus on insulin resistance and Type2 DM in Egyptian patients (prospective study)Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(4): 2641 doi: 10.1016/j.dsx.2019.07.032
139
Xiao Liu, Xiaoqiong Duan, Jacinta A. Holmes, Wenting Li, Sae Hwan Lee, Zeng Tu, Chuanlong Zhu, Shadi Salloum, Anna Lidofsky, Esperance A. Schaefer, Dachuan Cai, Shilin Li, Haoju Wang, Yongfu Huang, Yongju Zhao, Ming-Lung Yu, Zhiwen Xu, Limin Chen, Jian Hong, Wenyu Lin, Raymond T. Chung. A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6Hepatology 2019; 69(3): 1004 doi: 10.1002/hep.30266
140
Muhammad Usman Ashraf, Kanzal Iman, Muhammad Farhan Khalid, Hafiz Muhammad Salman, Talha Shafi, Momal Rafi, Nida Javaid, Rashid Hussain, Fayyaz Ahmad, Syed Shahzad‐Ul‐Hussan, Shaper Mirza, Muhammad Shafiq, Samia Afzal, Sadia Hamera, Saima Anwar, Romena Qazi, Muhammad Idrees, Sohail A. Qureshi, Safee Ullah Chaudhary. Evolution of efficacious pangenotypic hepatitis C virus therapiesMedicinal Research Reviews 2019; 39(3): 1091 doi: 10.1002/med.21554
141
Yun Lu, Xiuze Jin, Cheng-a-xin Duan, Feng Chang, Yury E Khudyakov. Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naïve patients in ChinaPLOS ONE 2018; 13(4): e0195117 doi: 10.1371/journal.pone.0195117
142
Joost W. Geenen, Cornelis Boersma, Olaf H. Klungel, Anke M. Hövels. Accuracy of budget impact estimations and impact on patient access: a hepatitis C case studyThe European Journal of Health Economics 2019;  doi: 10.1007/s10198-019-01048-z
143
Hosnieh Fathi, Andrew Clark, Nathan R. Hill, Geoffrey Dusheiko. Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic reviewBMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2820-z
144
Henrique Pott, Matheus Theodoro, Juliana de Almeida Vespoli, Jorge Figueiredo Senise, Adauto Castelo. Mother-to-child transmission of hepatitis C virusEuropean Journal of Obstetrics & Gynecology and Reproductive Biology 2018; 224: 125 doi: 10.1016/j.ejogrb.2018.03.034
145
Page Axley, Zunirah Ahmed, Sujan Ravi, Ashwani K. Singal. Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative ReviewJournal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00067
146
Ilya Bendich, Steven Takemoto, Joseph T. Patterson, Alexander Monto, Thomas C. Barber, Alfred C. Kuo. Preoperative Treatment of Hepatitis C Is Associated With Lower Prosthetic Joint Infection Rates in US VeteransThe Journal of Arthroplasty 2019; 34(7): S319 doi: 10.1016/j.arth.2019.02.052
147
Zurabi Lominadze, Robert S. Brown. Acute HCV Treatment: What Should We Do in the DAA Era?Current Hepatology Reports 2019; 18(2): 216 doi: 10.1007/s11901-019-00463-3
148
Roseline MINME, Iandra HOLZMANN, Cristiane Valle TOVO, Paulo Roberto Lerias de ALMEIDA. PROFILE OF PATIENTS WITH CHRONIC HEPATITIS C IN A PUBLIC HEALTH PROGRAM IN SOUTHERN BRAZILArquivos de Gastroenterologia 2018; 55(4): 403 doi: 10.1590/s0004-2803.201800000-86
149
V. Estrada, I. Sagastagoitia. Hepatitis C is a risk factor for cardiovascular diseaseRevista Clínica Española (English Edition) 2019;  doi: 10.1016/j.rceng.2019.03.005
150
Martin C. S. Wong, Jason L. W. Huang, Jacob George, Junjie Huang, Colette Leung, Mohammed Eslam, Henry L. Y. Chan, Siew C. Ng. The changing epidemiology of liver diseases in the Asia–Pacific regionNature Reviews Gastroenterology & Hepatology 2019; 16(1): 57 doi: 10.1038/s41575-018-0055-0
151
Stephen M. Davis, Danielle Davidov, Alfgeir L. Kristjansson, Keith Zullig, Adam Baus, Melanie Fisher, Nickolas Zaller. Qualitative case study of needle exchange programs in the Central Appalachian region of the United StatesPLOS ONE 2018; 13(10): e0205466 doi: 10.1371/journal.pone.0205466
152
Barrot H. Lambdin, Jennifer Lorvick, Jessie K. Mbwambo, John Rwegasha, Saria Hassan, Paula Lum, Alex H. Kral. Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, TanzaniaInternational Journal of Drug Policy 2017; 45: 64 doi: 10.1016/j.drugpo.2017.05.043
153
Peter A.C. Wing, Meleri Jones, Michelle Cheung, Sampath DaSilva, Connor Bamford, Wing-Yiu Jason Lee, Elihu Aranday-Cortes, Ana Da Silva Filipe, John McLauchlan, David Smith, William Irving, Morven Cunningham, Azim Ansari, Eleanor Barnes, Graham R. Foster. Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to SofosbuvirGastroenterology 2019;  doi: 10.1053/j.gastro.2019.05.007
154
Claudia Palladino, Ifeanyi Jude Ezeonwumelu, Rute Marcelino, Verónica Briz, Inês Moranguinho, Fátima Serejo, José Fernando Velosa, Rui Tato Marinho, Pedro Borrego, Nuno Taveira. Epidemic history of hepatitis C virus genotypes and subtypes in PortugalScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30528-0
155
Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Po-Cheng Liang, Ming-Yen Hsieh, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang, Jin-Ching Lee, Pei-Lun Lee, Chia-Yen Dai. Association between cryoglobulinemia and liver fibrosis in chronic hepatitis C patientsJournal of Gastroenterology and Hepatology 2018; 33(11): 1897 doi: 10.1111/jgh.14275
156
Jihene Bettaieb, Anissa Chouikha, Marwa Khedhiri, Ghassen Kharroubi, Malek Badreddine, Nabil Bel Hadj Hmida, Adel Gharbi, Walid Hammemi, Amel Sadraoui, Ahlem Ben Yahia, Zina Meddeb, Afif Ben Salah, Henda Triki. Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional studyArchives of Virology 2019;  doi: 10.1007/s00705-019-04308-8
157
Roya Kahyesh-Esfandiary, Zohreh-Azita Sadigh, Maryam Esghaei, Mohammad-Navid Bastani, Tahereh Donyavi, Alireza Najafi, Atousa Fakhim, Farah Bokharaei-Salim. Detection of HCV genome in peripheral blood mononuclear cells of Iranian seropositive and HCV RNA negative in plasma of patients with beta-thalassemia major: Occult HCV infectionJournal of Medical Virology 2019; 91(1): 107 doi: 10.1002/jmv.25279
158
O. C. Smibert, M. A. Paraskeva, G. Westall, Greg Snell. An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant RecipientsPediatric Drugs 2018; 20(6): 539 doi: 10.1007/s40272-018-0313-1
159
Crina Fofiu, Alina Boeriu, Felicia Coman, Alexandru Fofiu, Nikola Panic, Milutin Bulajic, Daniela Dobru. Interferon-Free Regimen: Equally Effective in Treatment Naive and Experienced HCV PatientsAnnals of Hepatology 2019; 18(1): 137 doi: 10.5604/01.3001.0012.7905
160
Esther Babady. Molecular Monitoring of Viral InfectionsAdvances in Molecular Pathology 2018; 1(1): 65 doi: 10.1016/j.yamp.2018.06.006
161
K. G. Young, K. Haq, S. MacLean, R. Dudani, S. M. Elahi, R. Gilbert, R. D. Weeratna, L. Krishnan. Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigensJournal of Viral Hepatitis 2018; 25(6): 649 doi: 10.1111/jvh.12856
162
Valentina Pecoraro, Rita Banzi, Elisabetta Cariani, Johanna Chester, Erica Villa, Roberto D'Amico, Vittorio Bertele', Tommaso Trenti. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled TrialsJournal of Clinical and Experimental Hepatology 2018;  doi: 10.1016/j.jceh.2018.07.004
163
Masoud Behzadifar, Hassan Abolghasem Gorji, Nicola Luigi Bragazzi. The prevalence of hepatitis C virus infection in thalassemia patients in Iran from 2000 to 2017: a systematic review and meta-analysisArchives of Virology 2018; 163(5): 1131 doi: 10.1007/s00705-018-3767-0
164
Tatsuki Mizuochi, Tomoko Takano, Tadahiro Yanagi, Kosuke Ushijima, Mitsuyoshi Suzuki, Yoko Miyoshi, Yoshinori Ito, Ayano Inui, Hitoshi Tajiri. Epidemiologic features of 348 children with hepatitis C virus infection over a 30-year period: a nationwide survey in JapanJournal of Gastroenterology 2018; 53(3): 419 doi: 10.1007/s00535-017-1351-0
165
Shu-Mei Tsai, Jung-Ta Kao, Yun-Fang Tsai. Illness trajectory of initial infection for patients with hepatitis C: A qualitative studyNursing & Health Sciences 2019; 21(1): 112 doi: 10.1111/nhs.12568
166
Alaa Badawi, Giancarlo Di Giuseppe, Paul Arora, Hans Tillmann. Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017)PLOS ONE 2018; 13(12): e0208839 doi: 10.1371/journal.pone.0208839
167
Henrique Pott, Guilherme Bricks, Jorge Figueiredo Senise, Adauto Castelo. CHRONIC Alcohol ABUSE and spontaneous clearance of hepatitis C virusIDCases 2019; : e00534 doi: 10.1016/j.idcr.2019.e00534
168
E. R. Chernykh, E. A. Oleynik, O. Yu. Leplina, M. A. Tikhonova, T. V. Tyrinova, N. M. Starostina, A. A. Ostanin. Induction of HCV-specific cell response in vitro by dendritic cells generated with interferon-αRussian Journal of Infection and Immunity 2019; 9(1): 76 doi: 10.15789/2220-7619-2019-1-76-86
169
Letitia Shunmugam, Pritika Ramharack, Mahmoud E. S. Soliman. Road Map for the Structure-Based Design of Selective Covalent HCV NS3/4A Protease InhibitorsThe Protein Journal 2017; 36(5): 397 doi: 10.1007/s10930-017-9736-8
170
Francesca Ceccherini-Silberstein, Valeria Cento, Velia Chiara Di Maio, Carlo Federico Perno, Antonio Craxì. Viral resistance in HCV infectionCurrent Opinion in Virology 2018; 32: 115 doi: 10.1016/j.coviro.2018.10.005
171
Benli Jia, Dongsheng Yu, Gang Yu, Yunsheng Cheng, Yang Wang, Xiaoqiang Yi, Xiaoping Li, Yong Wang. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent mannerBiomedicine & Pharmacotherapy 2018; 103: 746 doi: 10.1016/j.biopha.2018.04.110
172
Li-Ting Xie, Chun-Hong Yan, Qi-Yu Zhao, Meng-Na He, Tian-An Jiang. Quantitative and noninvasive assessment of chronic liver diseases using two-dimensional shear wave elastographyWorld Journal of Gastroenterology 2018; 24(9): 957-970 doi: 10.3748/wjg.v24.i9.957
173
William B. Coleman, Gregory J. Tsongalis. Molecular Pathology2018; : 231 doi: 10.1016/B978-0-12-802761-5.00012-2
174
Vasil B. Krapchev, Malgorzata Rychłowska, Alicja Chmielewska, Karolina Zimmer, Arvind H. Patel, Krystyna Bieńkowska-Szewczyk. Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in miceVirology 2018; 519: 33 doi: 10.1016/j.virol.2018.03.026
175
Navaneethan Palanisamy, Dario Akaberi, Johan Lennerstrand. Protein backbone flexibility pattern is evolutionarily conserved in the Flaviviridae family: A case of NS3 protease in Flavivirus and HepacivirusMolecular Phylogenetics and Evolution 2018; 118: 58 doi: 10.1016/j.ympev.2017.09.015
176
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Immunopathogenesis of Liver Injury During Hepatitis C Virus InfectionViral Immunology 2019; 32(3): 112 doi: 10.1089/vim.2018.0124
177
Zabihollah Shoja, Maryam Chenari, Ali Jafarpour, Somayeh Jalilvand. Role of iron in cancer development by virusesReviews in Medical Virology 2019; : e2045 doi: 10.1002/rmv.2045
178
Benedetto Caroleo, Lidia Colangelo, Maria Perticone, Giovambattista De Sarro, Luca Gallelli. Efficacy and Safety of Elbasvir-Grazoprevir Fixed Dose in the Management of Polytreated HCV Patients: Evidence From Real-Life Clinical PracticeThe Journal of Clinical Pharmacology 2018; 58(10): 1248 doi: 10.1002/jcph.1135
179
Z. M. Younossi, A. Tanaka, Y. Eguchi, L. Henry, R. Beckerman, M. Mizokami. Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in JapanJournal of Viral Hepatitis 2018; 25(8): 945 doi: 10.1111/jvh.12886
180
Reinhard H. Dennin. Current HIV Prevention Policies Are Jeopardizing the “End of AIDS” Project: Realities Counteract Liberal VisionsWorld Journal of AIDS 2017; 7(02): 138 doi: 10.4236/wja.2017.72012
181
H. Y. Choi, Y. Kim, H. Cho, B. H. Kim, M. Ki. Risk of diabetes in viral hepatitis B or C patients compared to that in noninfected individuals in Korea, 2002-2013: A population-based cohort studyJournal of Viral Hepatitis 2018; 25(3): 272 doi: 10.1111/jvh.12815
182
Ming-Shyan Lin, Chang-Min Chung, Ming-Ling Chang, Mei-Yen Chen, Shih-Tai Chang, Pao-Hsien Chu, Tien-Hsing Chen, Wey-Yil Lin, Tung-Jung Huang, Yu-Sheng Lin. The Unraveled Link Between Antiviral Therapy and Heart Failure Hospitalization in Chronic Hepatitis C Virus Infection ― A Nationwide Cohort Study ―Circulation Journal 2018; 82(6): 1623 doi: 10.1253/circj.CJ-17-1118
183
Rui Huang, Huiying Rao, Qing Xie, Zhiliang Gao, Wu Li, Deyuan Jiang, Hongmei Mo, Benedetta Massetto, Luisa M. Stamm, Diana M. Brainard, Lai Wei. Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infectionJournal of Medical Virology 2019; 91(7): 1313 doi: 10.1002/jmv.25454
184
Xiaoqiong Duan, Xiao Liu, Wenting Li, Jacinta A. Holmes, Annie J. Kruger, Chunhui Yang, Yujia Li, Min Xu, Haiyan Ye, Shuang Li, Xinzhong Liao, Qiuju Sheng, Dong Chen, Tuo Shao, Zhimeng Cheng, Batul Kaj, Esperance A. Schaefer, Shilin Li, Limin Chen, Wenyu Lin, Raymond T. Chung. Microrna-130a Downregulates HCV Replication through an atg5-Dependent Autophagy PathwayCells 2019; 8(4): 338 doi: 10.3390/cells8040338
185
Aiko Fukui, Naoto Kawabe, Senju Hashimoto, Hiroyuki Kamei, Kentaro Yoshioka. Skeletal muscle mass depletion in patients with hepatitis C virus infectionEuropean Journal of Gastroenterology & Hepatology 2019; 31(1): 59 doi: 10.1097/MEG.0000000000001255
186
Taciana Pereira Sant'Ana Santos, Mariana de Menezes Pereira, Maria Isabel Schinoni, Geraldo Pedral Sampaio, Roque Aras, Maria Luiza Sousa Atta, Ajax M. Atta. Atherogenic cytokines and chemokines in chronic hepatitis C are not associated with the presence of cardiovascular diseasesCytokine 2019; 115: 24 doi: 10.1016/j.cyto.2018.12.005
187
Jiuhong Zha, Bifeng Ding, Haoyu Wang, Weihan Zhao, Chen Yu, Katia Alves, Niloufar Mobashery, Yan Luo, Rajeev M. Menon. Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese PatientsEuropean Journal of Drug Metabolism and Pharmacokinetics 2019; 44(1): 43 doi: 10.1007/s13318-018-0492-8
188
H Elalfy, T Besheer, MA El-Maksoud, K Farid, M Elegezy, AM El Nakib, MA El-Aziz, AA El-Khalek, A El-Morsy, A Elmokadem, AZ Elsamanoudy, M El-Bendary. Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolizationBritish Journal of Biomedical Science 2018; 75(4): 187 doi: 10.1080/09674845.2018.1494769
189
James E. Squires, William F. Balistreri. Hepatitis C virus infection in children and adolescentsHepatology Communications 2017; 1(2): 87 doi: 10.1002/hep4.1028
190
Bin Wei, Fanpu Ji, Yee Hui Yeo, Eiichi Ogawa, Biyao Zou, Christopher D Stave, Shuangsuo Dang, Zongfang Li, Norihiro Furusyo, Ramsey C Cheung, Mindie H Nguyen. Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysisBMJ Open Gastroenterology 2018; 5(1): e000207 doi: 10.1136/bmjgast-2018-000207
191
Yoshimi Shimizu, Yoshitaka Shirasago, Masuo Kondoh, Tetsuro Suzuki, Takaji Wakita, Kentaro Hanada, Kiyohito Yagi, Masayoshi Fukasawa, Michael S. Diamond. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse ModelJournal of Virology 2018; 92(8): e02258-17 doi: 10.1128/JVI.02258-17